The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin.


BACKGROUND The aim of this study was to investigate whether high-sensitivity C-reactive protein (hsCRP) levels prior to cardioversion (CV) predict recurrence of atrial fibrillation (AF) in patients randomized to treatment with either atorvastatin or placebo 30 and 180 days after CV. METHODS This was a prespecified substudy of 128 patients with persistent… (More)
DOI: 10.1016/j.ijcard.2012.05.071


  • Presentations referencing similar topics